0 items USD 0.00Search
Your search for "mrrpb5 global herceptin biosimilar market research report 2019" gave back 83406 results.
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Herceptin Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Herceptin Biosimilar is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Herceptin (Trastuzumab) and Biosimilar market size is expected to reach $ 6357.7 million by 2029, rising at a market growth of 4.6% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Herceptin (Trastuzumab) and Biosimilar market size is projected to grow from US$ 4413.9 million in 2022 to US$ 6202.2 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Herceptin (Trastuzumab) and Biosimilar market size was valued at USD 4642.6 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Summary The global Herceptin Biosimilar market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define,...
Catalog:
HYR
January 2022
Price: USD 1,800.00
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Trastuzumab market size was valued at US$ million in 2023. With growing demand in downstream market, the Trastuzumab is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Trastuzumab Monoclonal Antibody market size is expected to reach $ 6357.7 million by 2029, rising at a market growth of 4.6% CAGR during...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Trastuzumab Monoclonal Antibody market size is projected to grow from US$ 4413.9 million in 2022 to US$ 6202.2 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
